Basit öğe kaydını göster

dc.contributor.authorCakiroglu, Duygu
dc.contributor.authorMeral, Yuecel
dc.contributor.authorBakirel, Utku
dc.contributor.authorKazanci, Didem
dc.date.accessioned2020-06-21T15:08:28Z
dc.date.available2020-06-21T15:08:28Z
dc.date.issued2009
dc.identifier.issn1300-6045
dc.identifier.urihttps://hdl.handle.net/20.500.12712/18976
dc.descriptionmeral, yucel/0000-0001-9099-5061en_US
dc.descriptionWOS: 000263698100003en_US
dc.description.abstractThis Study was designed to determine plasma cTnI and cTnT concentrations in dogs with DCM and to investigate the value of these two parameters in this type of heart disease, For this purpose, 11 dogs with DCM diagnosed, via electrocardiographic and echocardiographic examinations nearby apparent clinical heart disease symptoms were studied. The correlation coefficients between serum CK, cTnI and cTnT values were determined insignificant and no important relationship was calculated between these values. High cTnI levels were determined for 10 of 11 (90.9%) dogs with DCM, while high cTnT levels were determined for 7 of 11 (63.6%) clogs with DCM. It is suggested that cardiac Troponins, especially cTnI is a strong candidate as a cardiac biomarker in animals.en_US
dc.language.isoengen_US
dc.publisherKafkas Univ, Veteriner Fakultesi Dergisien_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectTroponinen_US
dc.subjectCreatinin Kinaseen_US
dc.subjectCardiomyopathyen_US
dc.subjectDogen_US
dc.titleCardiac Troponin Levels in Dogs with Dilate Cardiomyopathyen_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume15en_US
dc.identifier.issue1en_US
dc.identifier.startpage13en_US
dc.identifier.endpage17en_US
dc.relation.journalKafkas Universitesi Veteriner Fakultesi Dergisien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster